Kevin R. Kupcho

Promega (United States)

Papers

2

Total Citations

65

H-Index

2

About

Kevin R. Kupcho is a biochemist and assay technology developer whose research has made meaningful contributions to the field of high-throughput screening and enzyme activity measurement. Working at the intersection of biochemistry and drug discovery, Kupcho has focused on developing innovative, practical tools for studying protein kinases and phosphatases — two critically important enzyme families involved in cellular signaling and disease pathways. His most influential contribution, a homogeneous, nonradioactive fluorogenic protein kinase assay published in 2003, has garnered 49 citations and represented a significant methodological advancement in the field. By moving away from traditional radioactive approaches, Kupcho's work offered researchers a safer, more scalable, and equally reliable means of measuring kinase activity — a development with clear implications for pharmaceutical screening programs. His follow-up work in 2004 extended this platform to protein phosphatases, further broadening the toolkit available to researchers studying signal transduction. Kupcho's contributions reflect a talent for translating biochemical challenges into elegant, practical solutions. His assay development work has equipped laboratories worldwide with cleaner, more efficient methods for investigating enzyme function, supporting both fundamental research and the accelerated discovery of therapeutic compounds.

Research Focus

Key Achievements

2
H-Index
2
Papers
65
Total Citations
33
Avg Citations/Paper
🏆 Most Cited Paper
A homogeneous, nonradioactive high-throughput fluorogenic protein kinase assay
49 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Promega (United States)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago